ScoreWhy is Changjiang Pharmaceutical Group Co., Ltd. ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -29.96% and Operating profit at -6.04% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
The company has declared Negative results for the last 14 consecutive quarters
- NET SALES(HY) At CNY 113.23 MM has Grown at -51.39%
- NET PROFIT(HY) At CNY -288.1 MM has Grown at -74%
- INTEREST(HY) At CNY 85.05 MM has Grown at 472.23%
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -61.13%, its profits have fallen by -107.3%
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -61.13% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Auto Components & Equipments)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Changjiang Pharmaceutical Group Co., Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Changjiang Pharmaceutical Group Co., Ltd.
-68.63%
0.06
67.29%
China Shanghai Composite
14.77%
1.01
15.10%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-29.96%
EBIT Growth (5y)
-6.04%
EBIT to Interest (avg)
0.72
Debt to EBITDA (avg)
6.36
Net Debt to Equity (avg)
-1.50
Sales to Capital Employed (avg)
0.59
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.85%
ROE (avg)
7.33%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-2.39
EV to EBIT
-2.84
EV to EBITDA
-2.96
EV to Capital Employed
3.45
EV to Sales
24.70
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-121.71%
ROE (Latest)
Negative BV
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend13What is working for the Company
NET SALES(Q)
At CNY 103.07 MM has Grown at 277.72%
NET PROFIT(HY)
Higher at CNY -288.1 MM
ROCE(HY)
Highest at 0%
RAW MATERIAL COST(Y)
Fallen by -39.02% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at -150.29 %
OPERATING PROFIT MARGIN(Q)
Highest at -55.61 %
PRE-TAX PROFIT(Q)
At CNY -89.4 MM has Grown at 70.4%
-26What is not working for the Company
NET SALES(HY)
At CNY 113.23 MM has Grown at -51.39%
NET PROFIT(HY)
At CNY -288.1 MM has Grown at -74%
INTEREST(HY)
At CNY 85.05 MM has Grown at 472.23%
DEBTORS TURNOVER RATIO(HY)
Lowest at 0.1%
CASH AND EQV(HY)
Lowest at CNY 17.31 MM
INVENTORY TURNOVER RATIO(HY)
Lowest at 3.84%
Here's what is working for Changjiang Pharmaceutical Group Co., Ltd.
Net Sales
At CNY 103.07 MM has Grown at 277.72%
over average net sales of the previous four periods of CNY 27.29 MMMOJO Watch
Near term sales trend is extremely positive
Net Sales (CNY MM)
Net Profit
Higher at CNY -288.1 MM
than preceding 12 month period ended Mar 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (CNY MM)
Net Sales
Highest at CNY 103.07 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Operating Profit Margin
Highest at -55.61 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
At CNY -89.4 MM has Grown at 70.4%
over average net sales of the previous four periods of CNY -302 MMMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Debt-Equity Ratio
Lowest at -150.29 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by -39.02% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Changjiang Pharmaceutical Group Co., Ltd.
Net Profit
At CNY -288.1 MM has Grown at -74%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Interest
At CNY 85.05 MM has Grown at 472.23%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Debtors Turnover Ratio
Lowest at 0.1% and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Cash and Eqv
Lowest at CNY 17.31 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Inventory Turnover Ratio
Lowest at 3.84%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
